CN101209324B

CN101209324B - 'Penqiangjin' capsule

Info

Publication number: CN101209324B
Application number: CN200710144104XA
Authority: CN
Inventors: 周鑫
Original assignee: Individual
Current assignee: Individual
Priority date: 2007-12-25
Filing date: 2007-12-25
Publication date: 2011-05-18
Anticipated expiration: 2027-12-25
Also published as: CN101209324A

Abstract

The invention relates to a medical preparation which contains the reaction products of the plant materials, in particular to a pelvic cleaning capsule for the treatment of female pelvic inflammatory disease. The technical proposal adopted by the invention is that: the invention is a medicament prepared by the ingredients with the following weight ratio: 4 to 9g of sanchi, 2 to 5g of rhubarb, 4 to 9g of Szechwan Chinaberry fruit, 2 to 6g of combined spicebush root, 10 to 15g of sphenomeris chinensis, 2 to 6g of pedate pinallia jackinthepulpit rhizome and 10 to 15g of Philippine violet herb. The invention has the advantage that: the invention is a pure Chinese herbal medicinal capsule preparation---pelvic cleaning capsule. The invention takes the effects of clearing heat, removing toxicity, promoting diuresis, removing blood stasis, stopping pain and activating qi as the treatment principle, and the invention achieves better efficacy on the treatment of pelvic inflammatory disease and the complications. A lot of clinical observations show that the pelvic cleaning capsule has convenient usage, no pain, no wound, economy and satisfied efficacy, so the invention is worth popularizing and using.

Description

The clean capsule of pelvic cavity

Technical field

The present invention relates to contain the medicinal preparation that derives from the vegetable material product, especially belong to a kind of clean capsule of pelvic cavity for the treatment of female pelvic inflammation.

Background technology

Pelvic inflammatory disease be meant female pelvic cavity genitals inflammation and around the be inflamed general designation of reaction of connective tissue and pelvic peritoneum, comprise metritis, adnexitis, inflammation of pelvic connective tissue and pelvic cavity film inflammation etc., be one of common gynecological disease.The common pathogenic factor of pelvic inflammatory disease is childbirth and postabortal infection, and unhygienic custom, sexual life, sexual intercourse in menstrual period etc. all can cause the intrusion of pathogen and cause inflammation.At present, adopt naturopathy and chemotherapy, but curative effect can not be satisfactory for the treatment of pelvic inflammation more.

Summary of the invention

The object of the present invention is to provide the clean capsule of pelvic cavity of a kind of wound easy to use, safe, painless, no and directly oral treatment female pelvic inflammation.

The technical solution used in the present invention is: it is that one-tenth by following weight ratio is distributed into medicament:

Radix Notoginseng 4-9g Radix Et Rhizoma Rhei 2-5g Fructus Toosendan 4-9g Radix Linderae 2-6g

Folium Stenolomatis 10-15g Rhizoma Arisaematis 2-6g Herba Violae 10-15g.

Beneficial effect of the present invention is: the present invention is a kind of capsule preparations of pure Chinese crude drug--the clean capsule of-pelvic cavity.It is with the heat-clearing and toxic substances removing dampness removing, and the blood-activating analgetic circulation of qi promoting is the Therapeutic Principle, and treatment pelvic inflammatory disease and complication thereof have obtained curative effect preferably.By a large amount of clinical observations, the clean capsule of pelvic cavity is easy to use, and painless, no wound and economical and practical, satisfactory effect are worth of widely use.

Theory of Chinese medical science is inquired into: the not record of " pelvic inflammatory disease " name of disease in motherland's medical science, but can be summarized as among the diseases such as " invasion of the blood-chamber by heat ", " leukorrheal diseases ", " damp-heat in lower-JIAO ", " gynecological mass in abdomen ", " irregular menstruation ", " through row clothes pain ", " infertile " according to its clinical manifestation.And the traditional Chinese medical science thinks that this disease is that damp and hot malicious heresy is taken advantage of a weak point, and pents up the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels because of menstrual period, puerperal vessels of the uterus inanition more, and the visitor violates uterus, pelvic cavity, meridians impatency, coagulation of QI-blood, and battalion defends imbalance, and influence is dashed and is appointed due to the dai channel.So based on heat-clearing and toxic substances removing dampness removing, blood-activating analgetic circulation of qi promoting, kidney, Chong and Ren Meridians regulating then are the rule of treatment of treatment pelvic inflammatory disease again to be aided with training unit.

At present, Western medicine still lacks a kind of effective Therapeutic Method to this disease.The present invention is based on Basic Theories of Chinese Medicine,, develop a kind of capsule preparations--clean capsule of forming by pure Chinese crude drugs such as Radix Notoginseng, Radix Et Rhizoma Rhei, Fructus Toosendan, the Radix Linderae, Folium Stenolomatis, Rhizoma Arisaematis, Herba Violaes of-pelvic cavity in conjunction with clinical application.Radix Notoginseng in the side: invigorate blood circulation; Folium Stenolomatis: promoting diuresis to remove toxic substance; Herba Violae: detoxifcation disappears bitterly; Rhizoma Arisaematis: dispelling wind detoxifcation; Be Liver Channel tying-in with the Radix Linderae and Fructus Toosendan again, the Radix Et Rhizoma Rhei food stagnation removing is drawn poison and is gone out.The pure medical material of shared seven flavors of the clean capsule of pelvic cavity, the heat-clearing and toxic substances removing dampness removing, the blood-activating analgetic circulation of qi promoting improves local microcirculation, impels inflammation to absorb drug effect, thereby reaches therapeutic purposes.

The specific embodiment

Concrete formulation Example of the present invention is as follows:

Embodiment 1: it is that one-tenth by following weight ratio is distributed into medicament:

Radix Notoginseng 4g Radix Et Rhizoma Rhei 2g Fructus Toosendan 4g Radix Linderae 2g

Folium Stenolomatis 10g Rhizoma Arisaematis 2g Herba Violae 10g.

Embodiment 2: it is that one-tenth by following weight ratio is distributed into medicament:

Radix Notoginseng 9g Radix Et Rhizoma Rhei 5g Fructus Toosendan 9g Radix Linderae 6g

Folium Stenolomatis 15g Rhizoma Arisaematis 6g Herba Violae 15g.

Embodiment 3: it is that one-tenth by following weight ratio is distributed into medicament:

Radix Notoginseng 5g Radix Et Rhizoma Rhei 3g Fructus Toosendan 5g Radix Linderae 3g

Folium Stenolomatis 12g Rhizoma Arisaematis 3g Herba Violae 12g.

Embodiment 4: it is that one-tenth by following weight ratio is distributed into medicament:

Radix Notoginseng 7g Radix Et Rhizoma Rhei 4g Fructus Toosendan 7g Radix Linderae 4g

Folium Stenolomatis 14g Rhizoma Arisaematis 4g Herba Violae 14g.

The present invention is made up of pure Chinese crude drugs such as Radix Notoginseng, Radix Et Rhizoma Rhei, Fructus Toosendan, the Radix Linderae, Folium Stenolomatis, Rhizoma Arisaematis, Herba Violaes, and adopts conventional modern Chinese medicine manufacturing technology to be made through technologies such as the remove impurity of selecting materials, mixing crushing screening, weighing, glue capsules.

It is oral to get clean capsule 2 grams of pelvic cavity when the present invention uses, and one day twice, 45 day is a course of treatment.Period in a medicine is not taken other drug.

Therapeutic outcome of the present invention:

Diagnosis efficacy assessment standard according to " new Chinese medicine clinical research guideline " (trying) relevant chronic pelvic inflammatory disease:

Cure: clinical symptom disappearance, the gynecologial examination sign disappears, and the ultrasound diagnosis uterus adnexa is no abnormal.

Produce effects: cardinal symptom and sign are clearly better, the no abnormal discovery of ultrasound diagnosis.

Effectively: cardinal symptom and sign have improvement, and ultrasound diagnosis before take a favorable turn.

Invalid: clinical symptoms and sign do not see and alleviate, and checks no significant change before and after the B ultrasonic.

Below all medical records all from prosperous subhealth state institute of week, case is collected and to be lasted time a year and a half.60 routine infertile patients, 19 years old～47 years old age.Wherein 19 years old～25 years old person's 7 examples, 26 years old～35 years old person's 42 examples, 36～47 years old person's 11 example, 32.5 years old mean age.The course of disease 4 months～14 months.

Symptom is that hypogastric region weighs down bloated or pain, and lumbosacral region is ached, in menstrual period, fatigue or sexual intercourse postemphasis; Or have low grade fever, susceptible tired, and part patient occurs that lassitude, the whole body are uncomfortable, insomnia and rectal tenesmus, menoxenia, menorrhagia, infertile, leucorrhea amount increase, have stench flavor, and small number of patients has purulent leukorrhea etc.Gynecologial examination: the limited or adhesion of uterine activity is fixed, and the palace is other can to touch streak or lamellar thickens thing, and at the bottom of the palace or palace body has tenderness.The B ultrasonic prompting: attachment area increases slightly, the unclear or prompting adnexa enclosed mass (seeing capsule) of boundary more.

All patients accept further consultation after a course of treatment, and 42 examples of curing among the 60 routine patients account for 70%; 8 examples of produce effects account for 13.3%; Effective 7 examples account for 11.7%; 3 invalid examples account for 5%.Slightly feel itching of the throat or stifled sense after wherein having 2 routine patients to take medicine.Carrying may be Rhizoma Arisaematis sensitivity in the medicine, and clothes crystal sugar glycyrrhiza decoction is alleviated.Small number of patients is after accepting second course of treatment in addition, and body recovery is normal.

Typical case's medical record:

Mrs Ma, woman, 28 years old, Brunei overseas Chinese.Summer in 2005, invited the Brunei that goes abroad.The patient examines because of the huge pain of waist, and looking into lower back has a streak strong rope lump.Because of wouldn't making a definite diagnosis,, stop pin to menstruation in the 5th day so, subtract greatly bitterly with acupuncture " Ah being " cave and the relevant acupuncture point of waist.Cross further consultation in 7 days, after inquiry, be diagnosed as pelvic inflammatory disease.Impose the clean capsule for treating of pelvic cavity, subjective symptoms obviously alleviates after 15 days, after continued to take 1 month, transference cure, body recovery is normal.Gynecologial examination is normal, and B ultrasonic is looked into and shown that pelvic cavity is no abnormal.

Claims

1. capsule for the treatment of pelvic inflammatory disease is characterized in that: it is that one-tenth by following weight ratio is grouped into its active component:

Folium Stenolomatis 10-15g Rhizoma Arisaematis 2-6g Herba Violae 10-15g.

2. capsule according to claim 1 is characterized in that: it is that one-tenth by following weight ratio is grouped into its active component:

Folium Stenolomatis 10g Rhizoma Arisaematis 2g Herba Violae 10g.

3. capsule according to claim 1 is characterized in that: it is that one-tenth by following weight ratio is grouped into its active component:

Folium Stenolomatis 15g Rhizoma Arisaematis 6g Herba Violae 15g.

4. capsule according to claim 1 is characterized in that: it is that one-tenth by following weight ratio is grouped into its active component:

Folium Stenolomatis 12g Rhizoma Arisaematis 3g Herba Violae 12g.

5. capsule according to claim 1 is characterized in that: it is that one-tenth by following weight ratio is grouped into its active component:

Folium Stenolomatis 14g Rhizoma Arisaematis 4g Herba Violae 14g.